Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial

Journal of Psychopharmacology

Volumn 29, Issue 6, 2015, Pages 678-687

  Nuijten, Mascha ^a   Blanken, Peter ^a   Van Den Brink, Wim ^b   Hendriks, Vincent ^a  

^a Parnassia Research Centre   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

cocaine dependence; crack cocaine dependence; medication adherence; Modafinil; randomised controlled trial; treatment retention

Indexed keywords

COCAINE; MODAFINIL; BENZHYDRYL DERIVATIVE; CYTOCHROME P450 3A INDUCER;

ADULT; AGITATION; ARTICLE; COCAINE DEPENDENCE; COGNITIVE THERAPY; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEASIBILITY STUDY; FEMALE; HEADACHE; HUMAN; INTENTION TO TREAT ANALYSIS; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NETHERLANDS; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; SOCIAL INTERACTION; TACHYCARDIA; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; COCAINE-RELATED DISORDERS; MIDDLE AGED; PATIENT COMPLIANCE; PROCEDURES;

BENZHYDRYL COMPOUNDS; COCAINE-RELATED DISORDERS; COGNITIVE THERAPY; CRACK COCAINE; CYTOCHROME P-450 CYP3A INDUCERS; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PATIENT COMPLIANCE; PATIENT SATISFACTION; TREATMENT OUTCOME;

EID: 84930665800     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115582151     Document Type: Article

References (80)

1. Ahmadi J, Kampman KM, Oslin DM, et al. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. Am J Addict. 2009 ; 18: 81-86
2. Alterman AI, McKay JR, Mulvaney FD, et al. Baseline prediction of 7-month cocaine abstinence for cocaine dependence patients. Drug Alcohol Depend. 2000 ; 59: 215-221
3. Alvarez Y, Farre M, Fonseca F, et al. Anticonvulsant drugs in cocaine dependence: A systematic review and meta-analysis. J Subst Abuse Treat. 2010 ; 38: 66-73
4. Alvarez Y, Perez-Mana C, Torrens M, et al. Antipsychotic drugs in cocaine dependence: A systematic review and meta-analysis. J Subst Abuse Treat. 2013 ; 45: 1-10
5. Amato L, Minozzi S, Pani PP, et al. Antipsychotic medications for cocaine dependence. Cochrane Database Syst Rev. 2007 ; 3: CD006306
6. Amato L, Minozzi S, Pani PP, et al. Dopamine agonists for the treatment of cocaine dependence. Cochrane Database Syst Rev. 2011 ; 12: CD003352
7. Diagnostic and Statistical Manual of Mental Disorders. 1994 ) Diagnostic and Statistical Manual of Mental Disorders. 4th edn.Washington, DC: American Psychiatric Publishing. Washington, DC: American Psychiatric Publishing ; 1994 :
8. Anderson AL, Li SH, Biswas K, et al. Modafinil for the treatment of methamphetamine dependence. Drug Alcohol Depend. 2012 ; 120: 135-141
9. Anderson AL, Reid MS, Li SH, et al. Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend. 2009 ; 104: 133-139
10. Anton RF, Moak DH, Latham PK. The obsessive compulsive drinking scale: A new method of assessing outcome in alcoholism treatment studies. Arch Gen Psychiatry. 1996 ; 53: 225-231
11. Arrindell WA, Ettema JHM SCL-90: Handleiding bij een multidimensionele psychopathologie-indicator. Lisse: Swets en Zeitlinger ; 1986 :
12. Carroll KM, Kiluk BD, Nich C, et al. Toward empirical identification of a clinically meaningful indicator of treatment outcome: Features of candidate indicators and evaluation of sensitivity to treatment effects and relationship to one year follow up cocaine use outcomes. Drug Alcohol Depend. 2014 ; 137: 3-19
13. Castells X, Casas M, Perez-Mana C, et al. Efficacy of psychostimulant drugs for cocaine dependence. Cochrane Database Syst Rev. 2010 ; 2: CD007380
14. Cottler LB. The CIDI and CIDI-substance abuse module (SAM): Cross-cultural instruments for assessing DSM-III, DSM-III-R and ICD-10 criteria. NIDA Res Monogr. 1990 ; 105: 220-226
15. Cottler LB Composite International Diagnostic Interview - Substance Abuse Module (SAM). St Louis: Department of Psychiatry, Washington University School of Medicine ; 2000 :
16. Dackis CA, Kampman KM, Lynch KG, et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology. 2005 ; 30: 205-211
17. Dackis CA, Kampman KM, Lynch KG, et al. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. J Subst Abuse Treat. 2012 ; 43: 303-312
18. Dackis CA, Lynch KG, Yu E, et al. Modafinil and cocaine: A double-blind, placebo-controlled drug interaction study. Drug Alcohol Depend. 2003 ; 70: 29-37
19. De Wilde EF, Hendriks VM. The Client Satisfaction Questionnaire: Psychometric properties in a Dutch addict population. Eur Addict Res. 2005 ; 11: 157-162
20. De Wildt WA, Lehert P, Schippers GM, et al. Investigating the structure of craving using structural equation modeling in analysis of the obsessive-compulsive drinking scale: A multinational study. Alcohol Clin Exp Res. 2005 ; 29: 509-516
21. De Wildt WA, Schippers GM, Van Den, Brink W, et al. Does psychosocial treatment enhance the efficacy of acamprosate in patients with alcohol problems?. Alcohol Alcohol. 2002 ; 37: 375-382
22. DeFulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012 ; 55: S86 - S94
23. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012 ; 379: 55-70
24. Derogatis LR, Lipman RS, Covi L. SCL-90: An outpatient psychiatric rating scale - preliminary report. Psychopharmacol Bull. 1973 ; 9: 13-28
25. Dutra L, Stathopoulou G, Basden SL, et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008 ; 165: 179-187
26. Franken IH, Hendriks VM, van den Brink W. Initial validation of two opiate craving questionnaires: The Obsessive Compulsive Drug Use Scale and the Desires for Drug Questionnaire. Addict Behav. 2002 ; 27: 675-685
27. Hart CL, Haney M, Vosburg SK, et al. Smoked cocaine self-administration is decreased by modafinil. Neuropsychopharmacology. 2008 ; 33: 761-768
28. Hendriks VM, Kaplan CD, van Limbeek J, et al. The Addiction Severity Index: Reliability and validity in a Dutch addict population. J Subst Abuse Treat. 1989 ; 6: 133-141
29. Herin DV, Rush CR, Grabowski J. Agonist-like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Ann N Y Acad Sci. 2010 ; 1187: 76-100
30. Hjorthoj CR, Hjorthoj AR, Nordentoft M. Validity of Timeline Follow-Back for self-reported use of cannabis and other illicit substances - systematic review and meta-analysis. Addict Behav. 2012 ; 37: 225-233
31. Joos L, Goudriaan AE, Schmaal L, et al. Effect of modafinil on impulsivity and relapse in alcohol dependent patients: A randomized, placebo-controlled trial. Eur Neuropsychopharmacol. 2013 ; 23: 948-955
32. Kadden RM. Behavioral and cognitive-behavioral treatments for alcoholism: Research opportunities. Addict Behav. 2001 ; 26: 489-507
33. Kampman KM, Alterman AI, Volpicelli JR, et al. Cocaine withdrawal symptoms and initial urine toxicology results predict treatment attrition in outpatient cocaine dependence treatment. Psychol Addict Behav. 2001 ; 15: 52-59
34. Kampman KM, Leiderman D, Holmes T, et al. Cocaine Rapid Efficacy Screening Trials (CREST): Lessons learned. Addiction. 2005 ; 100: 102-110
35. Karila L, Gorelick D, Weinstein A, et al. New treatments for cocaine dependence: A focused review. Int J Neuropsychopharmacol. 2008 ; 11: 425-438
36. Kishi T, Matsuda Y, Iwata N, et al. Antipsychotics for cocaine or psychostimulant dependence: Systematic review and meta-analysis of randomized, placebo-controlled trials. J Clin Psychiatry. 2013 ; 74: e1169 - e1180
37. Knapp WP, Soares BG, Farrel M, et al. Psychosocial interventions for cocaine and psychostimulant amphetamines related disorders. Cochrane Database Syst Rev. 2007 ; 3: CD003023
38. Kokkevi A, Hartgers C. EuropASI: European adaptation of a multidimensional assessment instrument for drug and alcohol dependence. European Addiction Research. 1995 ; 1: 208-210
39. Kosten T, Domingo C, Orson F, et al. Vaccines against stimulants: cocaine and MA. Br J Clin Pharmacol. 2013 ; 77: 368-374
40. Larsen DL, Attkisson CC, Hargreaves WA, et al. Assessment of client/patient satisfaction: Development of a general scale. Eval Program Plann. 1979 ; 2: 197-207
41. Lingford-Hughes A, Welch S, Peters L, et al. BAP updated guidelines: Evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: Recommendations from BAP. J Psychopharmacol. 2012 ; 26: 899-952
42. Lussier JP, Heil SH, Mongeon JA, et al. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006 ; 101: 192-203
43. Malcolm R, Swayngim K, Donovan JL, et al. Modafinil and cocaine interactions. Am J Drug Alcohol Abuse. 2006 ; 32: 577-587
44. Mariani JJ, Levin FR. Psychostimulant treatment of cocaine dependence. Psychiatr Clin North Am. 2012 ; 35: 425-439
45. Marsden J, Gossop M, Stewart D, et al. The Maudsley Addiction Profile (MAP): A brief instrument for assessing treatment outcome. Addiction. 1998 ; 93: 1857-1867
46. McLellan AT, Kushner H, Metzger D, et al. The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat. 1992 ; 9: 199-213
47. Minozzi S, Amato L, Davoli M, et al. Anticonvulsants for cocaine dependence. Cochrane Database Syst Rev. 2008 ; 2: CD006754
48. Monti PM, Rohsenow DJ, Michalec E, et al. Brief coping skills treatment for cocaine abuse: Substance use outcomes at three months. Addiction. 1997 ; 92: 1717-1728
49. Nuijten M, Blanken P, van den Brink W, et al. Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): New pharmacological treatment options for crack-cocaine dependence in the Netherlands. BMC Psychiatry. 2011 ; 11: 135
50. Nuijten M, Blanken P, van den Brink W, et al. Treatment of crack-cocaine dependence with topiramate: A randomized controlled feasibility trial in The Netherlands. Drug Alcohol Depend. 2014 ; 138: 177-184
51. Pani PP, Trogu E, Vecchi S, et al. Antidepressants for cocaine dependence and problematic cocaine use. Cochrane Database Syst Rev. 2011 ; 12: CD002950
52. Perez-Mana C, Castells X, Vidal X, et al. Efficacy of indirect dopamine agonists for psychostimulant dependence: A systematic review and meta-analysis of randomized controlled trials. J Subst Abuse Treat. 2011 ; 40: 109-122
53. Petry NM, Rash CJ, Byrne S, et al. Financial reinforcers for improving medication adherence: Findings from a meta-analysis. Am J Med. 2012 ; 125: 888-896
54. Poling J, Kosten TR, Sofuoglu M. Treatment outcome predictors for cocaine dependence. Am J Drug Alcohol Abuse. 2007 ; 33: 191-206
55. Prendergast M, Podus D, Finney J, et al. Contingency management for treatment of substance use disorders: A meta-analysis. Addiction. 2006 ; 101: 1546-1560
56. Preti A. New developments in the pharmacotherapy of cocaine abuse. Addict Biol. 2007 ; 12: 133-151
57. Project MATCH (Matching Alcoholism Treatment to Client Heterogeneity): Rationale and methods for a multisite clinical trial matching patients to alcoholism treatment. Alcohol Clin Exp Res. 1993 ; 17: 1130-1145
58. Rohsenow DJ, Monti PM, Martin RA, et al. Brief coping skills treatment for cocaine abuse: 12-month substance use outcomes. J Consult Clin Psychol. 2000 ; 68: 515-520
59. Schmitz JM, Green CE, Stotts AL, et al. A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: Modafinil, levodopa-carbidopa, naltrexone. Drug Alcohol Depend. 2014 ; 136: 100-107
60. Schmitz JM, Rathnayaka N, Green CE, et al. Combination of modafinil and d-amphetamine for the treatment of cocaine dependence: A preliminary investigation. Front Psychiatry. 2012 ; 3: 77
61. Servick K. Biomedicine. 'Nonadherence': A bitter pill for drug trials. Science. 2014 ; 346: 288-289
62. Shearer J. Psychosocial approaches to psychostimulant dependence: A systematic review. J Subst Abuse Treat. 2007 ; 32: 41-52
63. Shearer J. The principles of agonist pharmacotherapy for psychostimulant dependence. Drug Alcohol Rev. 2008 ; 27: 301-308
64. Sinha R, Garcia M, Paliwal P, et al. Stress-induced cocaine craving and hypothalamic-pituitary-adrenal responses are predictive of cocaine relapse outcomes. Arch Gen Psychiatry. 2006 ; 63: 324-331
65. Sobell LC, Sobell MB Measuring Alcohol Consumption: Psychosocial and Biological Methods. Litten RZ Allen J, ed. Totowa: Humana Press ; 1992: 41-72.
66. Sofuoglu M, Gonzalez G, Poling J, et al. Prediction of treatment outcome by baseline urine cocaine results and self-reported cocaine use for cocaine and opioid dependence. Am J Drug Alcohol Abuse. 2003 ; 29: 713-727
67. Starosta AN, Leeman RF, Volpicelli JR. The BRENDA model: Integrating psychosocial treatment and pharmacotherapy for the treatment of alcohol use disorders. J Psychiatr Pract. 2006 ; 12: 80-89
68. Stitzer ML, Vandrey R. Contingency management: Utility in the treatment of drug abuse disorders. Clin Pharmacol Ther. 2008 ; 83: 644-647
69. Nationale drugmonitor - Jaarbericht 2012. Utrecht: Trimbos-instituut ; 2013 :
70. World Drug Report 2012. Vienna: United Nations Office on Drugs and Crime ; 2012 :
71. Van den Brink W. Evidence-based pharmacological treatment of substance use disorders and pathological gambling. Curr Drug Abuse Rev. 2012 ; 5: 3-31
72. Verrico CD, Haile CN, Mahoney JJ, et al. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: A randomized, double blind, placebo-controlled human laboratory study. Drug Alcohol Depend. 2014 ; 141: 72-78
73. Volkow ND, Fowler JS, Logan J, et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. JAMA. 2009 ; 301: 1148-1154
74. Volpicelli JR, Pettinati HM, McLellan AT, et al Combining Medication and Psychosocial Treatments for Addictions: The BRENDA Approach. New York: Guilford Press ; 2001 :
75. Weiss RD. Adherence to pharmacotherapy in patients with alcohol and opioid dependence. Addiction. 2004 ; 99: 1382-1392
76. Weiss RD, Griffin ML, Hufford C, et al. Early prediction of initiation of abstinence from cocaine. Use of a craving questionnaire. Am J Addict. 1997 ; 6: 224-231
77. Westhuis DJ, Gwaltney L, Hayashi R. Outpatient cocaine abuse treatment: Predictors of success. J Drug Educ. 2001 ; 31: 171-183
78. Wisselink DJ, Kuijpers WGT, Mol A Kerncijfers verslavingszorg 2013. LADIS: Landelijk Alcohol en Drugs Informatie Systeem. Houten: Stichting Informatie Voorziening Zorg (IVZ) ; 2014 :
79. Zack M, Poulos CX. Effects of the atypical stimulant modafinil on a brief gambling episode in pathological gamblers with high vs. low impulsivity. J Psychopharmacol. 2009 ; 23: 660-671
80. Zelen M. A new design for randomized clinical trials. N Engl J Med. 1979 ; 300: 1242-1245